There is a great need to improve the outlook for people facing urinary bladder cancer. especially for patients with invasive urothelial carcinoma (InvUC) which is lethal in 50% of cases. Improved outcomes for patients with InvUC could come from advances on several fronts including emerging immunotherapies. targeted therapies. https://dragonstradingrts.shop/product-category/figures/